1. Home
  2. KZIA vs BHAT Comparison

KZIA vs BHAT Comparison

Compare KZIA & BHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KZIA
  • BHAT
  • Stock Information
  • Founded
  • KZIA 1994
  • BHAT 2010
  • Country
  • KZIA Australia
  • BHAT China
  • Employees
  • KZIA N/A
  • BHAT N/A
  • Industry
  • KZIA Biotechnology: Pharmaceutical Preparations
  • BHAT Recreational Games/Products/Toys
  • Sector
  • KZIA Health Care
  • BHAT Consumer Discretionary
  • Exchange
  • KZIA Nasdaq
  • BHAT Nasdaq
  • Market Cap
  • KZIA 12.6M
  • BHAT 14.5M
  • IPO Year
  • KZIA 1999
  • BHAT 2019
  • Fundamental
  • Price
  • KZIA $4.90
  • BHAT $0.19
  • Analyst Decision
  • KZIA Strong Buy
  • BHAT
  • Analyst Count
  • KZIA 1
  • BHAT 0
  • Target Price
  • KZIA $20.00
  • BHAT N/A
  • AVG Volume (30 Days)
  • KZIA 148.4K
  • BHAT 431.4K
  • Earning Date
  • KZIA 11-19-2024
  • BHAT 12-20-2024
  • Dividend Yield
  • KZIA N/A
  • BHAT N/A
  • EPS Growth
  • KZIA N/A
  • BHAT N/A
  • EPS
  • KZIA N/A
  • BHAT N/A
  • Revenue
  • KZIA $382.00
  • BHAT $73,686,733.00
  • Revenue This Year
  • KZIA $4,053,954.00
  • BHAT N/A
  • Revenue Next Year
  • KZIA N/A
  • BHAT N/A
  • P/E Ratio
  • KZIA N/A
  • BHAT N/A
  • Revenue Growth
  • KZIA N/A
  • BHAT 3255.57
  • 52 Week Low
  • KZIA $1.90
  • BHAT $0.17
  • 52 Week High
  • KZIA $15.80
  • BHAT $1.45
  • Technical
  • Relative Strength Index (RSI)
  • KZIA 50.25
  • BHAT 32.17
  • Support Level
  • KZIA $5.21
  • BHAT $0.17
  • Resistance Level
  • KZIA $6.88
  • BHAT $0.24
  • Average True Range (ATR)
  • KZIA 0.76
  • BHAT 0.03
  • MACD
  • KZIA -0.11
  • BHAT -0.00
  • Stochastic Oscillator
  • KZIA 22.80
  • BHAT 19.57

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors.

About BHAT Blue Hat Interactive Entertainment Technology

Blue Hat Interactive Entertainment Technology is a producer, developer, and operator of augmented reality (AR) interactive entertainment games and toys in China, including interactive educational materials, mobile games, and toys with mobile game features. The company's products include AR Racer, AR Crazy Bug, AR 3D Magic Box, AR Dinosaur, Talking Tom and Friends Bouncing Bubble, and Immersive Education Classes. The company reports in the following segments: Interactive toys - animation series, Interactive toys - game series, and Mobile games, Information services, and Communication services, out of which the majority of the revenue is generated from the game series. The majority of its revenues are generated in China.

Share on Social Networks: